Edwards Lifesciences Europe

Follow us to engage with our societal mission #UnifyingGenerations, fight #CardiovascularDisease, or for #MedTech & corp. updates from @EdwardsLifesci in Europe

[Economía 3 @Economia_3]

Segundo premio de la tarde, esta vez a la #Innovación a @EdwardsEurope  , empresa líder a nivel mundial en innovación cardiaca estructural.

#innovacion #edwardslifesciences #PremiosEconomia3 #Valencia #grupoemotiva

[Edwards Lifesciences Europe @EdwardsEurope]

➡ The effects of ageism in healthcare impact everyone: individuals, families and societies, by failing to recognise the potential of older generations to contribute to society.

The "𝗖𝗼𝗻𝗳𝗿𝗼𝗻𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗶𝘀𝗺 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲" report, produced by Gupta Strategists and supported by Edwards Lifesciences, explores age discrimination across the Dutch healthcare system 🇳🇱 and advocates for age-neutral policies, better education for healthcare providers, and inclusive research to ensure older adults receive the care they deserve.

Find out more: https://t.co/ifKK8ppo7L

#AgeDiscrimination #HealthcareForAll #HealthcareInnovation #HealthcareEquity #AgeismAwareness

[Edwards Lifesciences Europe @EdwardsEurope]

🏥🇳🇱 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝗲𝘃𝗲𝗿𝘆 𝘆𝗲𝗮𝗿, 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝟰𝟱𝟬,𝟬𝟬𝟬 𝗮𝗻𝗱 𝟲𝟱𝟬,𝟬𝟬𝟬 𝗼𝗹𝗱𝗲𝗿 𝗮𝗱𝘂𝗹𝘁𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗡𝗲𝘁𝗵𝗲𝗿𝗹𝗮𝗻𝗱𝘀 𝗳𝗮𝗰𝗲 𝗺𝗶𝘀𝘀𝗲𝗱 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗲𝘀, 𝗱𝗲𝗹𝗮𝘆𝗲𝗱 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀, 𝗮𝗻𝗱 𝗿𝗲𝗱𝘂𝗰𝗲𝗱 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗰𝗮𝗿𝗲 due to ageism.

It’s time to address the gap.

Find out more here in the latest Gupta Strategists report: https://t.co/ifKK8ppo7L

#AgeDiscrimination #HealthcareForAll #HealthcareInnovation #HealthcareEquity #AgeismAwareness

[Edwards Lifesciences Europe @EdwardsEurope]

🫀🇪🇺 This week, 𝘁𝗵𝗲 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗨𝗻𝗶𝗼𝗻 𝗺𝗮𝗱𝗲 𝗵𝘂𝗴𝗲 𝘀𝘁𝗲𝗽𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝘁 𝗼𝗳 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘀𝘂𝗳𝗳𝗲𝗿𝗶𝗻𝗴 𝗳𝗿𝗼𝗺 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝗶𝘀𝗲𝗮𝘀𝗲! European Countries adopted Council Conclusions on Cardiovascular Health, which marks a historic milestone for cardiovascular patients all over Europe! This sets the stage for the first-ever EU Cardiovascular Health Plan to tackle EU’s biggest killer.

“By prioritizing cardiovascular health, the European Union is taking a transformative step that will impact millions of lives for the years to come.

As pioneers in structural heart disease innovation, we will continue to push boundaries, collaborating with stakeholders to transform care and improve outcomes for patients.

We welcome the European union's strong commitment to heart health paving the way for a healthier future”- Annette Brüls, Edwards Lifesciences’ Corporate Vice President EMEA, Canada, and Latin America.

The future plan promises to improve prevention, early detection, and equitable access to innovative treatment.

Read more on: https://t.co/X76kM3Mo5Y

#CVHealth #CVHealthPlan #CVD #Cardiovascular

[Edwards Lifesciences Europe @EdwardsEurope]

Let’s talk about age discrimination and the 𝘂𝗻𝗱𝗲𝗿𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 & 𝘂𝗻𝗱𝗲𝗿𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗶𝗻 𝗼𝗹𝗱𝗲𝗿 𝗮𝗱𝘂𝗹𝘁𝘀.

The "𝗖𝗼𝗻𝗳𝗿𝗼𝗻𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗶𝘀𝗺 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲" report, produced by Gupta Strategists and supported by Edwards Lifesciences, explores age discrimination across the Dutch healthcare system 🇳🇱 .

For actionable solutions to drive equitable care, click here to learn more: https://t.co/ifKK8ppo7L

#AgeDiscrimination #HealthcareForAll #HealthcareInnovation #HealthcareEquity #AgeismAwareness

[European Alliance for Cardiovascular Health (EACH) @EUCVHAlliance]

The #CouncilConclusions being approved is not the only announcement of today! Commissioner for Health Mr Olivér Várhelyi states that the European Commission "will develop a new European Cardiovascular Health Plan", as it aims to "put front and centre cardiovascular health" in the new mandate, an ambition EACH Partners have been calling for! This is great news for the cardiovascular community across Europe! https://t.co/ZDLegbEBO9 #EUCVHPlan #CVHealthForAll

[Edwards Lifesciences Europe @EdwardsEurope]

Big thank you to everyone involved for their research and contributions at #ISPOREurope 2024, making innovation possible and improving patient care.

[Edwards Lifesciences Europe @EdwardsEurope]

A Look back at our participation at this year's #ISPOREurope held in Barcelona. ISPOR is a leading global conference where experts discuss and share the latest Health economics and outcomes research (#HEOR) .

Our team, together with academic partners, presented several impactful research posters. These posters highlighted the latest evidence and findings in Structural Heart Disease and medical devices, driven by our commitment and involvement to improving patient care and healthcare efficiency.

🧵An overview of the different posters presented.

[Edwards Lifesciences Europe @EdwardsEurope]

Global Assessment of Pre-Market Approval Pathways for Medical Devices: Highlighting the Need for Harmonization 🧬

This study from SDA Bocconi, presented by Francesco Malandrini calls for more consistent regulations for approving medical devices to make it easier to bring new treatments to market.

🔗https://t.co/NjhH5CcdoR

[HEU-EFS @HEUEFS]

In celebration of #WorldScienceDay, this year’s theme, #GlobalScience for #GlobalWellbeing, highlights the role of science in global health.

Join @HEUEFS in advancing medical science. Engage with our survey to shape the future of #MedTech in Europe.
🔗https://t.co/SoPfMd4Qn5

[Edwards Lifesciences Europe @EdwardsEurope]

🔊 It was an impactful moment for us as Annette Brüls, our Corporate Vice President EMEA, Canada, and Latin America, addressed EU and national policymakers and decision-makers as a speaker during the closing plenary session of #StateOfEU organized by @FriendsofEurope , the leading EU think tank.

She was part of a panel that included Charles Wyplosz (Economist, and Emeritus Professor at Geneva Graduate School), Leena Yla-Mononen (Executive Director, European Environment Agency), and Mario Monti (Italian Senator, former Prime Minister and EU commissioner).

Her message was clear: Aligning capital with ambitions is essential to support innovation in Europe and meet the needs of the people in the union. She emphasized the urgent need for regulatory change to make life-saving innovations more accessible across Europe. Despite groundbreaking MedTech advancements, patients often face many years of waiting to benefit from them. A faster, more efficient path for innovation is clearly needed to meet health needs.

🔗 Catch up on all the discussions that took place during the event here: https://t.co/axD1aOLYQ3

#StateOfEU #FutureOfEurope #HealthcareForAll

[Friends of Europe @FriendsofEurope]

Stressing the need for Europe to become the 'hub' for innovation, Annette Brüls - @EdwardsEurope urges Europe to speed up access to innovation.

“I think we need to radically accelerate access to #innovation. Today in Europe, it takes 3 years or more before breakthrough innovations reach patients who desperately need it, while these #treatments are already accessible in the US, Canada, Japan and Australia. So we need to be more straightforward and pilot and test new approaches.”

[Friends of Europe @FriendsofEurope]

🔈 “I’m convinced that embracing innovation should be at the heart of a #RenewedSocialContract. Europe has always been at the forefront of innovation,” Annette Brüls - @EdwardsEurope, contends as she joins our #StateOfEU closing session.

[Friends of Europe @FriendsofEurope]

🔴 STARTING NOW | Join the closing session of our 21st edition #StateOfEU high-level roundtable as we tackle the crucial question: is Europe’s budget fit for its ambitions?

🇪🇺 This key discussion will address the pressing need for a #fiscal strategy that aligns with Europe’s goals of leadership in green tech, industrial innovation and social equity; within the reality of current #budget constraints.

We are honoured to welcome distinguished discussants:
🎙️ @SenatoreMonti, Italian Senator for life, Senate Committee on Foreign Affairs and Defence, former Italian prime minister, former European commissioner and Trustee of @FriendsofEurope
🎙️ Annette Brüls, Corporate Vice President EMEA, Canada, Latin America @EdwardsLifesci
🎙️@YlaLeena, Executive Director @EUEnvironment
🎙️ @CharlesWyplosz, Economist and Emeritus Professor @GVAGrad

👉 Watch live: https://t.co/c9ptwcN3hf

🧵 Follow this thread for more.